SKTO Breaks Higher After Consolidation

AEGY Announces Exclusive Marketing Agreement with SKTO; Discusses Share Volume
LOS ANGELES, May 21, 2013 /PRNewswire via COMTEX/ -- Alternative Energy Partners, Inc. (OTCBB: AEGY) announces that it has signed an agreement with SK3 Group, Inc. to become the exclusive on-line and smart phone ordering platform for Collectives managed through the SK3 Group system. Members of the Collectives managed by SK3 Group will soon be able to order their medical cannabis needs through PharmaJanes(TM).

In response to numerous requests regarding the increase in share volume in the trading market recently, AEGY's President, Mario Barrera, stated: "After reviewing recent large volume stock sales of AEGY common stock, and information provided by our transfer agent, it appears that 120,942,945 common shares have been issued as the result of conversions of convertible promissory notes held by Asher Enterprises, Inc. in just the past 10 days. The promissory notes being converted, which were issued by AEGY's prior management, allow the principal and accrued interest to be converted into common stock at a conversion price equal to about 50% of the average of the three lowest bid prices for the common stock during the prior 10 trading days. Due to the low bid price prior to the recent increase in both price and trading activity, these conversions by Asher Enterprises have resulted in very large issues of common stock to it, which are then being sold immediately into the market. It does not appear there are, and management is not aware of, any sales by management, any other affiliates or other large shareholders affiliated with the company. Hopefully, this activity will gradual reduce itself as the Asher notes are converted, at higher conversion prices."

Safe Harbor StatementSafe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes", "expects", "anticipates" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements to differ materially from those expressed or implied by such forward-looking statements. This news release speaks as of the date first set forth above and no responsibility or obligation may be assumed or exists to update the information included herein for events occurring after the date hereof.

Contact:Mario BarreraInfo@pharmajanes.com